Company intelligence / Profile preview

Lirio

Knoxville, Tennessee, United Stateslirio.com ↗

Ownership: Private
Employees: ~51
Development stage: Commercial

Overview

Lirio’s platform has demonstrated success in improving patient engagement, closing gaps in care, and supporting chronic disease management through hyper-personalized digital communications. It is actively used by major health systems such as Cone Health to improve outcomes for diabetes and hypertension patients. No traditional clinical trial results are reported as the company operates a SaaS model focused on population-level behavior change.

Therapeutic areas: OtherEndocrinologyCardiovascularInfectious Diseases
Modalities: Non-pharmacological therapy (behavioral interventions)Digital engagement platform
Industry: Digital Health Medical Devices

Partnerships

Cone Health (strategic partnership for chronic condition interventions)Community Health Network

Beyond the preview

Go deeper on Lirio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lirio.

Explore the full profile